VNDA logo

VNDA
Vanda Pharmaceuticals Inc

5,551
Mkt Cap
$420.85M
Volume
11.68M
52W High
$9.94
52W Low
$3.81
PE Ratio
-1.91
VNDA Fundamentals
Price
$7.12
Prev Close
$8.57
Open
$8.59
50D MA
$7.78
Beta
0.70
Avg. Volume
4.62M
EPS (Annual)
-$3.74
P/B
1.29
Rev/Employee
$405,450.28
$268.44
Loading...
Loading...

About

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
533

Frequently Asked Questions

What is Market Cap of Vanda Pharmaceuticals Inc?
What is the 52-week high for Vanda Pharmaceuticals Inc?
What is the 52-week low for Vanda Pharmaceuticals Inc?
What is Vanda Pharmaceuticals Inc stock price today?
What was Vanda Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Vanda Pharmaceuticals Inc?
What is the Price-to-Book ratio of Vanda Pharmaceuticals Inc?
What is the 50-day moving average of Vanda Pharmaceuticals Inc?
How many employees does Vanda Pharmaceuticals Inc have?

Latest VNDA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.